Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MaxCyte ( (MXCT) ) has provided an announcement.
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings, with BlackRock, Inc. acquiring or disposing of voting rights, resulting in a total of 7.65% voting rights held. This notification highlights BlackRock’s significant influence in MaxCyte, potentially impacting the company’s governance and strategic decisions.
More about MaxCyte
YTD Price Performance: -40.43%
Average Trading Volume: 34,071
Technical Sentiment Signal: Buy
Current Market Cap: £204.2M
For an in-depth examination of MXCT stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue